Oxford Ledge
Search
Johnson & Johnson (NYSE: JNJ) is a $635.1B drug manufacturers - general company trading at $261.44 (+1.9% today) — 30.4× trailing earnings, yielding 1.95%. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:47 UTC.
Johnson & Johnson is a holding company with approximately 138,200 employees worldwide that researches, develops, manufactures, and sells healthcare products. The company operates through two business segments: Innovative Medicine and MedTech, conducting business in virtually all countries. The Innovative Medicine segment focuses on prescription medications across therapeutic areas including oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular conditions, distributing products through retailers, wholesalers, distributors, hospitals, and healthcare…
Summarized from Johnson & Johnson’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
| Quote | |
| Price | $261.44 |
| Change (1D) | +4.96 (+1.93%) |
| Market cap | $635.1B |
| Valuation | |
| P/E (TTM) | 30.36× |
| EPS (TTM) | $8.61 |
| Dividend yield | 1.95% |
| Debt/equity | 0.58 |
Johnson & Johnson is a holding company with approximately 138,200 employees worldwide that researches, develops, manufactures, and sells healthcare products.
JNJ trades at $261.44, 30.36× trailing earnings, as of 2026-10-11. It carries a 1.95% dividend yield.
Johnson & Johnson's most recent SEC filing on record is a 8-K filed 2026-08-04. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:47 UTC. This page is also available as JSON at /api/data?ticker=JNJ and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for JNJ and 5,000+ tickers.
Create a free account — keep JNJGET /api/data?ticker=JNJ
This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt